4,5,7-Trichloro-1,6-naphthyridine

Catalog No.: 
ACSQZK957
CAS No.: 
2089301-45-9
Molecular Formula: 
C8H3Cl3N2
Molecular Weight: 
233.49
4,5,7-Trichloro-1,6-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$241.00InquiryInquiry
1g97%$772.00InquiryInquiry
5g97%$3783.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5,7-Trichloro-1,6-naphthyridine
IUPAC Name4,5,7-trichloro-1,6-naphthyridine
MDL No.MFCD30528660
Molecular FormulaC8H3Cl3N2
Molecular Weight233.49
SMILESClC1=NC(Cl)=C2C(Cl)=CC=NC2=C1
InChI KeyPXJOMWSHSNZNRP-UHFFFAOYSA-N
Synonym4,5,7-Trichloro-1,6-naphthyridine;1,6-Naphthyridine, 4,5,7-trichloro-
CAS No.2089301-45-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSQZK957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDYOZ356 route compound structure diagram
    ACDYOZ3562587-02-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSQZK957 route product structure diagram
    ACSQZK9572089301-45-9
Inquiry

2. ACSQZK957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDYOZ356 route compound structure diagram
    ACDYOZ3562587-02-2In Stock
  4. Then
  5. ACSQZK957 route product structure diagram
    ACSQZK9572089301-45-9
Inquiry

3. ACSQZK957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSQZK957 route product structure diagram
    ACSQZK9572089301-45-9
Inquiry

Comments (0)